190 related articles for article (PubMed ID: 3456076)
21. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
22. Update: acquired immunodeficiency syndrome--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):17-21. PubMed ID: 3079867
[TBL] [Abstract][Full Text] [Related]
23. Virologic studies in a case of transfusion-associated AIDS.
Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P
N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus isolation studies and antibody testing. Household contacts and sexual partners of persons with hemophilia.
Brettler DB; Forsberg AD; Levine PH; Andrews CA; Baker S; Sullivan JL
Arch Intern Med; 1988 Jun; 148(6):1299-301. PubMed ID: 3288158
[TBL] [Abstract][Full Text] [Related]
25. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children.
Greenberg AE; Nsa W; Ryder RW; Medi M; Nzeza M; Kitadi N; Baangi M; Malanda N; Davachi F; Hassig SE
N Engl J Med; 1991 Jul; 325(2):105-9. PubMed ID: 2052043
[TBL] [Abstract][Full Text] [Related]
29. AIDS: outcome of children born to HTLV-III/LAV infected mothers. Report of 15 Italian cases.
Aricò M; Azzini M; Caselli D; Maccario R; Marseglia G; Michelone G
Helv Paediatr Acta; 1986 Mar; 41(6):477-86. PubMed ID: 3473060
[TBL] [Abstract][Full Text] [Related]
30. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
31. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
Ory HW; Koplan JP; Allen JR
Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
[TBL] [Abstract][Full Text] [Related]
32. Acquired immunodeficiency syndrome and HTLV-III/LAV infection.
Rogers MF; Lifson AR
Semin Adolesc Med; 1986 Jun; 2(2):163-73. PubMed ID: 3474746
[TBL] [Abstract][Full Text] [Related]
33. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1). Experience from southwestern Saudi Arabia.
al-Nozha MM; al-Frayh AR; al-Nasser M; Ramia S
Trop Geogr Med; 1995; 47(6):293-5. PubMed ID: 8650743
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological trends of AIDS in the United States.
Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
[TBL] [Abstract][Full Text] [Related]
35. HIV infection through normal heterosexual contact in Uganda.
Sewankambo NK; Carswell JW; Mugerwa RD; Lloyd G; Kataaha P; Downing RG; Lucas S
AIDS; 1987 Jul; 1(2):113-6. PubMed ID: 3130076
[TBL] [Abstract][Full Text] [Related]
36. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
[TBL] [Abstract][Full Text] [Related]
37. LAV/HTLV-III infection in children of African origin: experience in Belgium.
Jonckheer T; Levy J; Van de Perre P; Thiry L; Henrivaux P; Sacré JP; Schepens G; Mees N; Dab I; Taelman H
Eur J Pediatr; 1986 Dec; 145(6):511-6. PubMed ID: 2949977
[TBL] [Abstract][Full Text] [Related]
38. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Dec; 34(48):721-6, 731-2. PubMed ID: 2999576
[TBL] [Abstract][Full Text] [Related]
39. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
[TBL] [Abstract][Full Text] [Related]
40. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
